期刊文献+

23例大疱性类天疱疮回顾性临床分析

Retrospective clinical analysis of 23 patients with bullous pemphigoid
下载PDF
导出
摘要 目的总结大疱性类天疱疮的临床特点及治疗经验。方法回顾性分析2013年4月至2014年4月在我院皮肤科住院治疗的23例大疱性类天疱疮患者入院时的一般情况、实验室检查及临床疗效。结果轻、中度患者激素控制剂量(以泼尼松为标准量)分别为0.72±0.11mg/kg·d、1.35±0.40mg/kg·d,差异均有统计学意义(P<0.01)。无粘膜受累组与粘膜受累组患者激素控制剂量分别为1.38±0.45mg/kg·d、2.01±0.37mg/kg·d,差异有统计学意义(P<0.01)。结论大疱性类天疱疮患者的激素治疗不良反应发生率高,应权衡利弊,以获得最佳收益。 Objective To summarize the clinical features and effective treatment for bullous pemphigoid.Methods To retrospectively analyze the clinical data of 23 cases with bullous pemphigoid from April 2013 to April 2014 in department of dermatology,Binzhou Medical University Affiliated Hospital.Results The dose of corticosteroids was 0.72±0.11 mg/kg·d and1.35±0.40mg/kg·d based on baseline affected BSA of less than 30%,30%-50%,respectively.The dose of corticosteroids was 1.38±0.45mg/kg·d and 2.01±0.37mg/kg·d,based on whether the mucosal lesions occurred(P〈0.01).Conclusion The hormonotherapy has a higher rate of adverse reaction,so we should choose a proper treatment for the patients with bullous pemphigoid to get the best returns.
作者 范海燕 高昱
出处 《滨州医学院学报》 2016年第1期51-53,共3页 Journal of Binzhou Medical University
关键词 大疱性类天疱疮 糖皮质激素 免疫抑制剂 回顾性分析 bullous pemphigoid corticosteroids immunosuppressive agents retrospective analysis
  • 相关文献

参考文献6

二级参考文献31

  • 1朱学骏,李冠群.52例大疱性类天疱疮的预后及其影响因素分析[J].中华皮肤科杂志,1993,26(2):116-117. 被引量:7
  • 2郭绍兰,金始宇.恶性肿瘤合并大疱性类天疱疮6例报告[J].安徽医学,2005,26(5):455-455. 被引量:1
  • 3王娣,陈喜雪,朱学骏.124例大疱性类天疱疮治疗回顾[J].中华皮肤科杂志,2007,40(1):7-9. 被引量:30
  • 4林麟,靳培英,王峰来,马林,桑红桂.大疱性类天疱疮抗原分子异质性与临床的关系[J].中华皮肤科杂志,1997,30(1):13-15. 被引量:3
  • 5汤慈美.额叶.神经心理学[M].北京:人民军医出版社,2001.33-46.
  • 6Li L,Chen J,Wang B,et al.Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain.Br J Dermatol,2009,160(6):1343-1345.
  • 7Czernik A,Bystryn JC.Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents:marked improvement in depletion of circulating autoantibodies.Arch Dermatol,2008,144(5):658-661.
  • 8Bernard P,Reguiai Z,Tancrède-Bohin E,et al.Risk factors for relapse in patients with bullous pemphigoid in clinical remission:a multicenter,prospective,cohort study.Arch Dermatol,2009,145(5):537-542.
  • 9Joly P,Benichou J,Lok C,et al.Prediction of survival for patients with bullous pemphigoid:a prospective study.Arch Dermatol,2005,141(6):691-698.
  • 10朱学骏 郭英年.大疱性类天疱疮的糖皮质激素治疗[J].中华皮肤科杂志,1986,19:282-283.

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部